| May 19, 2013
| 8:22 AM
WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...
| Oct 6, 2013
| 9:00 AM
BEIJING — If you want a full-time teaching job, but you're stuck in a temporary gig without health benefits, Luo Chunlei advises that you buy the school principal a box of mooncakes and follow up with an envelope of dough.
Having an operation?...
| May 29, 2013
| 3:18 PM
The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease.
Advanced melanoma has joined a wide range...
| May 30, 2013
After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...
| May 30, 2013
| 4:16 PM
NEW YORK (Reuters Health) - Popular smoking cessation treatments - such as nicotine replacements and antidepressants - improve people's chances of kicking the habit without much risk, according to a review of past research.
"It seems very clear that...
| Jun 5, 2013
| 6:00 AM
One of the many ways in which humans' evolved characteristics clash with a fast-changing post-industrial society can be seen in the female egg.
Even before a woman passes the age of 30, the quality of the oocytes she carries begins a downturn in...
| Jun 5, 2013
| 4:35 PM
Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions.
| Jun 6, 2013
| 5:06 PM
An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
| Jul 1, 2013
| 4:30 AM
More than a dozen firefighters in Arizona died this weekend, political demonstrations in Brazil were suppressed by more than 10,000 troops, and Egypt is seeing resurgent political demonstrations of its own. Welcome to your post-weekend trends report for...
| Jul 16, 2013
| 4:36 PM
Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials.
Researchers examined data from thousands of experiments...
| Jul 25, 2013
| 11:47 AM
WASHINGTON (Reuters) - Only slightly more than half of U.S. girls aged 13 to 17 had been vaccinated against a virus that can cause cervical and other cancers last year, and a top U.S. health official said on Thursday that more must be done to bring the...